These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

935 related items for PubMed ID: 17892140

  • 1. [CEOP regimen in the treatment for non-Hodgkin's lymphoma].
    Huang HQ, Lin XB, Pan ZH, Bu Q, Gao Y, Wang BF, Cai QQ, Xia ZJ, Xu RH, Jiang WQ, Guan ZZ.
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):391-5. PubMed ID: 17892140
    [Abstract] [Full Text] [Related]

  • 2. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX.
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [Abstract] [Full Text] [Related]

  • 3. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
    Pan ZH, Huang HQ, Lin XB, Xia YF, Xia ZJ, Peng YL, Cai QQ, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
    [Abstract] [Full Text] [Related]

  • 4. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
    Lambertenghi Deliliers G, Butti C, Baldini L, Ceriani A, Lombardi F, Luoni M, Montalbetti L, Pavia G, Pinotti G, Pogliani E.
    Haematologica; 1995 Dec; 80(4):318-24. PubMed ID: 7590500
    [Abstract] [Full Text] [Related]

  • 5. [Long-term outcomes of 392 non-Hodgkin's lymphoma patients treated with pirarubicin based regimens].
    Huang HQ, Peng YL, Cai QQ, Lin XB, Li YH, Xia ZJ, Lin TY, Sun XF, Zhang L, Xu GC, He YJ, Jiang WQ, Guan ZZ.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):577-80. PubMed ID: 16532963
    [Abstract] [Full Text] [Related]

  • 6. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 7. [Preliminary outcome for patients with relapsed or resistant advanced non-Hodgkin's lymphoma treated by EPOCH regimen].
    Huang HQ, Jiang WQ, Wang W, Zhou ZM, Xia ZJ, Lin XB, Li YH, Xu RH, Zhang L, Xu GC, Sun XF, Liu DG, He YJ, Guan ZZ.
    Ai Zheng; 2003 Apr; 22(4):389-92. PubMed ID: 12703995
    [Abstract] [Full Text] [Related]

  • 8. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil].
    Qin Y, Shi YK, He XH, Yang JL, Yang S, Yu YX, Li B, Wang QL, Zhou LQ, Sun Y.
    Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685
    [Abstract] [Full Text] [Related]

  • 9. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY, Zhao XM, Cao JN, Hu XC, Yin JL, Hong XN, Li J.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
    Rossini F, Terruzzi E, Perego D, Miccolis I, Rivolta F, Manca E, Pogliani EM.
    Cancer; 2004 Jan 15; 100(2):350-5. PubMed ID: 14716771
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ, Bu Q, Xia ZJ, Lin XB, Wang FH, Li YH, Peng YL, Pan ZH, Wang SS, Lin TY, Jiang WQ, Guan ZZ.
    Ai Zheng; 2006 Apr 15; 25(4):486-9. PubMed ID: 16613686
    [Abstract] [Full Text] [Related]

  • 12. [Prognostic factors of invasive non-Hodgkin's lymphoma].
    Yu H, Hong XN, Li J, Peng LP, Ye L.
    Zhonghua Zhong Liu Za Zhi; 2007 Jun 15; 29(6):461-3. PubMed ID: 17974284
    [Abstract] [Full Text] [Related]

  • 13. [Clinical outcomes of patients with peripheral T-cell lymphoma (PTCL) treated by EPOCH regimen].
    Peng YL, Huang HQ, Lin XB, Xia ZJ, Li YH, Wang W, He YJ, Pan ZH, Jiang WQ, Guan ZZ.
    Ai Zheng; 2004 Aug 15; 23(8):943-6. PubMed ID: 15301720
    [Abstract] [Full Text] [Related]

  • 14. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B, Li YX, Fang H, Jin J, Liu XF, Yu ZH.
    Ai Zheng; 2006 Apr 15; 25(4):465-70. PubMed ID: 16613682
    [Abstract] [Full Text] [Related]

  • 15. Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
    Economopoulos T, Dimopoulos MA, Mellou S, Pavlidis N, Samantas E, Nicolaides C, Tsatalas C, Papadopoulos A, Papageogriou E, Papasavvas P, Fountzilas G.
    Eur J Haematol; 2002 Mar 15; 68(3):135-43. PubMed ID: 12068793
    [Abstract] [Full Text] [Related]

  • 16. [MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
    Fan Y, Huang ZY, Luo LH, Yu HF.
    Ai Zheng; 2005 Dec 15; 24(12):1503-6. PubMed ID: 16351801
    [Abstract] [Full Text] [Related]

  • 17. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
    Huang HQ, Peng YL, Lin XB, Sun XF, Lin TY, Xia ZJ, Li YH, Cai QQ, He YJ, Jiang WQ, Guan ZZ.
    Ai Zheng; 2004 Nov 15; 23(11 Suppl):1443-7. PubMed ID: 15566653
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M, Cartron G, Rachieru P, LeMevel A, Branger B, Le Maignan C, Berthou C, Ghandour C, Delwail V, Milpied N, Cassasus P, Celigny PS, Guyotat D, Lamy T, Desablens B, French GOELAMS Group.
    Haematologica; 2005 Jun 15; 90(6):802-9. PubMed ID: 15951293
    [Abstract] [Full Text] [Related]

  • 19. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
    Yao B, Li YX, Song YW, Jin J, Liu YP, Wang WH, Wang SL, Sun YT, Yu ZH, Liu XF.
    Zhonghua Zhong Liu Za Zhi; 2006 Jan 15; 28(1):58-61. PubMed ID: 16737624
    [Abstract] [Full Text] [Related]

  • 20. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck.
    Nishioka T, Tsuchiya K, Nishioka S, Kitahara T, Ohmori K, Homma A, Aoyma H, Shindoh M, Shirato H.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):847-52. PubMed ID: 15465202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.